Literature DB >> 24084407

Outcomes of a head and neck cancer screening clinic.

Andrew G Shuman1, Janet T McKiernan, Dorothy Thomas, Prateek Patel, Frank L Palmer, Brian T Shaffer, Jatin P Shah, Snehal G Patel, Jay O Boyle.   

Abstract

OBJECTIVE: To describe an institutional experience conducting an annual free head and neck (H&N) cancer screening clinic. Specific aims included: (1) identifying factors predicting which individuals will have findings suspicious for malignancy; and (2) evaluating potential barriers to subsequent follow-up among patients with suspicious findings.
MATERIALS AND METHODS: This retrospective cohort study involved individuals presenting to an annual H&N cancer screening clinic (2001-2012). Original screening clinic data and electronic medical records were reviewed. Descriptive and comparative statistics were utilized in order to address the study aims.
RESULTS: Of 1573 participants, 325 (21%) had abnormal findings on screening, of which 183 (12%) had findings suspicious for cancer. No demographic factors predicted a suspicion for cancer. The presence of patient-reported symptoms (16% vs. 8%; p<0.001) were significantly associated with a suspicion for cancer. Only 20% of individuals with a suspicion for cancer returned to our institution for recommended follow-up. Patients who did not complain of symptoms were less likely to return for follow-up (2% vs. 36%; p<0.001). Of the patients who returned for follow-up evaluation, malignancies were diagnosed in three patients.
CONCLUSION: Few individuals presenting to a H&amp;N cancer screening clinic will have a malignancy detected, and barriers may influence patients' likelihood to present for subsequent evaluation. Due to self-selection among patients presenting for screening, traditional risk factors may not be associated with the likelihood of detecting a suspicion for H&amp;N cancer. Head and neck cancer screening clinics should thus target patients at high risk, and attempt to ensure appropriate follow-up thereafter.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer screening; Community outreach; Head and neck cancer

Mesh:

Year:  2013        PMID: 24084407     DOI: 10.1016/j.oraloncology.2013.09.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  4 in total

1.  Investigating Patient and Physician Delays in the Diagnosis of Head and Neck Cancers: a Canadian Perspective.

Authors:  Jonghun John Lee; Chris Dhepnorrarat; Joyce Nyhof-Young; Ian Witterick
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

2.  Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.

Authors:  Theresa L Whiteside; Robert L Ferris; Miroslaw Szczepanski; Mitchell Tublin; Joseph Kiss; Rita Johnson; Jonas T Johnson
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

Review 3.  PPARγ in head and neck cancer prevention.

Authors:  Mauricio Burotto; Eva Szabo
Journal:  Oral Oncol       Date:  2014-01-13       Impact factor: 5.337

4.  Lifestyle risk factor related disparities in oral cancer examination in the U.S: a population-based cross-sectional study.

Authors:  Aderonke A Akinkugbe; Dina T Garcia; Tegwyn H Brickhouse; Maghboeba Mosavel
Journal:  BMC Public Health       Date:  2020-01-31       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.